Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 27 October

Sophia Mavridis
October 27, 2021

Morning Bell 26 October

Paulina Peters
October 26, 2021

Morning Bell 25 October

Sophia Mavridis
October 25, 2021

Weekly Wrap 22 October

Sophia Mavridis
October 22, 2021

Morning Bell 21 October

Paulina Peters
October 21, 2021

Morning Bell 20 October

Jessica Amir
October 20, 2021

Morning Bell 19 October

Jessica Amir
October 19, 2021

Morning Bell 18 October

Jessica Amir
October 18, 2021

Weekly Wrap 15 October

Jessica Amir
October 15, 2021

Morning Bell 15 October

Paulina Peters
October 15, 2021

Morning Bell 14 October

Jessica Amir
October 14, 2021

Morning Bell 13 October

Jessica Amir
October 13, 2021